The novel predictor of metabolic risk in patients with polycystic ovary syndrome: could it be the visceral adiposity index?

European review for medical and pharmacological sciences(2022)

引用 1|浏览3
暂无评分
摘要
After comparing data in groups with similar BMI levels, we found significantly high VAI values in patients with PCOS. The results reinforce the idea that VAI is a useful marker easily obtained in daily practice for assessing the cardiometabolic risk of patients with PCOS.
更多
查看译文
关键词
Cardiometabolic risk, Insulin resistance, Polycystic ovary syndrome, VAI
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要